Cargando…
TLR Agonist Therapy of Metastatic Breast Cancer in Mice
Toll-like receptor (TLR) 7/8 and 9 agonists stimulate an innate immune response that supports the development of tumor-specific immunity. Previous studies showed that either agonist individually could cure mice of small tumors and that when used in combination, they could prevent the progression of...
Autores principales: | Klinman, Dennis M., Goguet, Emilie, Tross, Debra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168108/ https://www.ncbi.nlm.nih.gov/pubmed/37103328 http://dx.doi.org/10.1097/CJI.0000000000000467 |
Ejemplares similares
-
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
por: Bayik, Defne, et al.
Publicado: (2018) -
Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
por: Zhao, By Gan, et al.
Publicado: (2014) -
PAM3 protects against DSS-induced colitis by altering the M2:M1 ratio
por: Horuluoglu, Begum H., et al.
Publicado: (2020) -
β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice
por: Jiang, Meng-Ping, et al.
Publicado: (2018)